CDCA8 and prostate carcinoma: In the latest published study on biomarkers of prostate cancer, hub genes such as KIF20A and CDCA8 are associated with adverse BCR-free survival of PCa patients and have better specificity and sensitivity in the diagnosis of prostate cancer [29].